Impact of Molecular Subtype Conversion of Breast Cancers After Neoadjuvant Chemotherapy on Clinical Outcome

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2014.262
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Cancer Association

Related search

Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy

World Journal of Surgical Oncology
SurgeryOncology
2018English

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Cancer Discovery
Oncology
2013English

O2-8-5Prognostic Value of Subtype Changes After Neoadjuvant Chemotherapy in Primary Breast Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

Associations of Lymphovascular Invasion and Clinical Outcomes in Breast Cancer After Neoadjuvant Chemotherapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Immune Contexture and Histological Response After Neoadjuvant Chemotherapy Predict Clinical Outcome of Lung Cancer Patients

OncoImmunology
OncologyAllergyImmunology
2016English

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Actual Conversion Rate From Total Mastectomy to Breast Conservation After Neoadjuvant Chemotherapy for Stages II–III Breast Cancer Patients

Journal of Breast Disease
2017English

Comparison of Pathologic Response Evaluation Systems After Anthracycline With/Without Taxane-Based Neoadjuvant Chemotherapy Among Different Subtypes of Breast Cancers

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy